These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24685014)

  • 1. Does specific interventional risk scoring better predict mortality than comorbidity in nonagenerians undergoing coronary angioplasty?
    Ormerod JO; Ramcharitar S
    Cardiovasc Revasc Med; 2014 Jun; 15(4):258-60. PubMed ID: 24685014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.
    Serruys PW; Farooq V; Vranckx P; Girasis C; Brugaletta S; Garcia-Garcia HM; Holmes DR; Kappetein AP; Mack MJ; Feldman T; Morice MC; Ståhle E; James S; Colombo A; Pereda P; Huang J; Morel MA; Van Es GA; Dawkins KD; Mohr FW; Steyerberg EW
    JACC Cardiovasc Interv; 2012 Jun; 5(6):606-17. PubMed ID: 22721655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.
    Head SJ; Holmes DR; Mack MJ; Serruys PW; Mohr FW; Morice MC; Colombo A; Kappetein AP;
    JACC Cardiovasc Interv; 2012 Jun; 5(6):618-25. PubMed ID: 22721656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of the logistic clinical SYNTAX score for predicting 1-year mortality in patients undergoing percutaneous coronary intervention of the left main coronary artery.
    Capodanno D; Giacoppo D; Dipasqua F; Miccichè E; Licitra C; Di Salvo ME; Francaviglia B; Grasso C; La Manna A; Sgroi C; Tamburino C
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E446-52. PubMed ID: 23592634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SYNTAX score and SYNTAX-based clinical risk scores.
    Farooq V; Brugaletta S; Serruys PW
    Semin Thorac Cardiovasc Surg; 2011; 23(2):99-105. PubMed ID: 22041038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.
    Hannan EL; Samadashvili Z; Walford G; Holmes DR; Jacobs AK; Stamato NJ; Venditti FJ; Sharma S; King SB
    JACC Cardiovasc Interv; 2010 Jan; 3(1):22-31. PubMed ID: 20129564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery?
    Yap CH; Yan BP; Akowuah E; Dinh DT; Smith JA; Shardey GC; Tatoulis J; Skillington PD; Newcomb A; Mohajeri M; Pick A; Seevanayagam S; Reid CM
    JACC Cardiovasc Interv; 2009 Aug; 2(8):758-64. PubMed ID: 19695544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization.
    Chakravarty T; Buch MH; Naik H; White AJ; Doctor N; Schapira J; Mirocha JM; Fontana G; Forrester JS; Makkar R
    Am J Cardiol; 2011 Feb; 107(3):360-6. PubMed ID: 21256999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexity of coronary artery disease affects outcome of patients undergoing coronary artery bypass grafting with impaired left ventricular function.
    Melina G; Angeloni E; Benedetto U; Monti F; Roscitano A; Serdoz R; Sinatra R
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):656-61. PubMed ID: 22995728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score.
    Farooq V; Vergouwe Y; Généreux P; Bourantas CV; Palmerini T; Caixeta A; Garcìa-Garcìa HM; Diletti R; Morel MA; McAndrew TC; Kappetein AP; Valgimigli M; Windecker S; Dawkins KD; Steyerberg EW; Serruys PW; Stone GW
    JACC Cardiovasc Interv; 2013 Jul; 6(7):737-45. PubMed ID: 23866185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry).
    Feldman DN; Gade CL; Slotwiner AJ; Parikh M; Bergman G; Wong SC; Minutello RM;
    Am J Cardiol; 2006 Nov; 98(10):1334-9. PubMed ID: 17134624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual SYNTAX score after PCI for triple vessel coronary artery disease: quantifying the adverse effect of incomplete revascularisation.
    Malkin CJ; George V; Ghobrial MS; Krishnan A; Siotia A; Raina T; Morton AC; Gunn J
    EuroIntervention; 2013 Mar; 8(11):1286-95. PubMed ID: 23538157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification following complex PCI: clinical versus anatomical risk stratification including "post PCI residual SYNTAX-score" as quantification of incomplete revascularization.
    Schwietz T; Spyridopoulos I; Pfeiffer S; Laskowski R; Palm S; DE Rosa S; Jens K; Zeiher AM; Schächinger V; Fichtlscherer S; Lehmann R
    J Interv Cardiol; 2013 Feb; 26(1):29-37. PubMed ID: 23419105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.
    Garg S; Serruys PW; Silber S; Wykrzykowska J; van Geuns RJ; Richardt G; Buszman PE; Kelbæk H; van Boven AJ; Hofma SH; Linke A; Klauss V; Wijns W; Macaya C; Garot P; DiMario C; Manoharan G; Kornowski R; Ischinger T; Bartorelli A; Van Remortel E; Ronden J; Windecker S
    JACC Cardiovasc Interv; 2011 Apr; 4(4):432-41. PubMed ID: 21511223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The New York State risk score for predicting in-hospital/30-day mortality following percutaneous coronary intervention.
    Hannan EL; Farrell LS; Walford G; Jacobs AK; Berger PB; Holmes DR; Stamato NJ; Sharma S; King SB
    JACC Cardiovasc Interv; 2013 Jun; 6(6):614-22. PubMed ID: 23787234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary interventions.
    Hannan EL; Samadashvili Z; Walford G; Holmes DR; Jacobs A; Sharma S; Katz S; King SB
    JACC Cardiovasc Interv; 2009 Apr; 2(4):350-6. PubMed ID: 19463449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision and accuracy of risk scores for in-hospital death after percutaneous coronary intervention in the current era.
    Brener SJ; Colombo KD; Haq SA; Bose S; Sacchi TJ
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):153-7. PubMed ID: 20095010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of patients undergoing rescue percutaneous coronary intervention: development and validation of a predictive tool.
    Burjonroppa SC; Varosy PD; Rao SV; Ou FS; Roe M; Peterson E; Singh M; Shunk KA
    JACC Cardiovasc Interv; 2011 Jan; 4(1):42-50. PubMed ID: 21251628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
    Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.